Celebrate the Dietary Supplement Health and Education Act with CRN

The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, invites you to join a month-long celebration of the 20th anniversary of the Dietary Supplement Health and Education Act (DSHEA). The celebratory effort will make strong use of CRN’s online platforms throughout the month of October, and involve consumer education; recognition of …

Adverse Event Reporting Webinar

Title: The Importance of a Robust Adverse Event Reporting System Date: Wednesday, October 29, 2014 Time: 2:00 PM Eastern / 11:00 AM Pacific Register here The What, When, Why and How of Serious Adverse Event Reporting Serious Adverse Event Reports (SAERs) should be a major concern for dietary supplement companies as adverse events can happen at any time. SAER issues …

SafetyCall Exhibiting and Presenting at IFT

SafetyCall International will be exhibiting at the 2014 IFT Annual Meeting, a conference which brings together professionals throughout the food industry, including experts in R&D, product development, and QA/QC.  SafetyCall will be at Booth #100.  Stop by to meet some of our key staff members and learn how we can help support product surveillance for reportable foods and dietary supplements. …

SafetyCall’s Accepted Poster Presentations at NACCT

Congratulations to SafetyCall’s Drs. Kelly Sioris and Dan Keyler as well as Dr. Rick Kingston, Dr. Dean Filandrinos, and Ryan Seaverson for getting their abstracts accepted to this year’s North American Congress of Clinical Toxicology (NACCT) meeting! Dr. Kelly Sioris and Dr. Dan Keyler submitted an abstract titled, “K2 and K9s.”  K2, or synthetic cannabinoids, have become increasingly prevalent in …

SafetyCall International Issues Statement Regarding Institute of Medicine’s Food and Dietary Supplement Workshop Summary

Additional post-market surveillance is required to accurately determine potential risks of products containing caffeine SafetyCall International today issued a statement in response to the Institute of Medicine’s (IOM) report released last week, “Examining Safety: Workshop Summary of Caffeine in Food and Dietary Supplements.” SafetyCall’s President of Regulatory and Scientific Affairs Dr. Richard Kingston, who participated in the workshop, stated that …

Dr. Kingston Awarded CSPA’s Chairman’s Outstanding Achievement Award for 2013

Rick Kingston, president, Regulatory and Scientific Affairs and Co-founder of SafetyCall International, is the co-recipient of the CSPA’s Chairman’s Outstanding Achievement Award for 2013. Kingston has been instrumental in developing and delivering training for the Consumer Specialty Products Association’s Product Care program. After implementing the initiative at his own company, Kingston mentored other CSPA member companies seeking to do the …

Webinar: The Buzz on Caffeine

Dr. Kingston will join a group of faculty to present a two hour webinar hosted by the Institute of Food Technologists.  More information on the webinar can be found here: http://www.ift.org/knowledge-center/learn-online/live-webcasts/the-buzz-on-caffeine.aspx “The Buzz on Caffeine: New Developments in Safety, Regulation and Adverse Event Reporting” Caffeine, a methylated xanthine, is the most widely used mild central nervous system stimulant, naturally present …

Caffeine Cards On The Table Following IOM Meeting

On August 5 and 6, Dr. Rick Kingston attended and briefly presented at the Workshop on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements, which was put on by the Institute of Medicine (IOM).  In follow up to the meeting, NutraIngredients-USA.com published an article on August 13th titled, “Caffeine cards are on table following IOM meeting, …

Dr. Kingston Comments at Institute of Medicine’s Caffeine Workshop

Dr. Rick Kingston provided comments at the Institute of Medicine’s Workshop on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements.  The two day workshop took place on August 5-6 in Washington DC and featured comments and presentations from various experts in the industry. Topics and discussions included: Evaluating the epidemiological, toxicological, clinical, and other relevant …